🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial will look at a drug called SEA-CD70 with and without azacitidine...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-08-07
Trial ID
NCT04227847
Treatments Being Tested
The purpose of this study is to determine if, once a favorable dose of TI I...
Status
Terminated
Location
Sansum Medical Research Institute
Start Date
2008-09
Trial ID
NCT00747006
Treatments Being Tested
Study designed to evaluate the safety and efficacy of MTS compared to place...
Status
Completed
Location
Multiple Locations
Start Date
2004-09
Trial ID
NCT00444574
Treatments Being Tested
This Phase1/2, open label, multicenter study will assess the safety, tolera...
Status
Recruiting
Location
Mayo Clinic Hospital - Arizona
Start Date
2025-01-09
Trial ID
NCT06706076
Treatments Being Tested
This is a Phase 1, first in human (FIH), Open-Label, Dose Escalation, Dose ...
Status
Recruiting
Location
Site-111
Start Date
2025-03-20
Trial ID
NCT06874335
Treatments Being Tested
Evaluate the possibility of optimization of therapy with prostanoids (ilopr...
Status
Completed
Location
Angiology, Hospital "G. Fucito"
Start Date
2006-11
Trial ID
NCT01718288
Treatments Being Tested
Thilao is a multi-country, phase 2b, non-randomized study, in Burkina Faso,...
Status
Unknown
Location
CHU Sourô Sanou
Start Date
2013-03
Trial ID
NCT02025868
A randomized controlled trial of Control-IQ, assessing glycemic control (ti...
Status
Completed
Location
University of Virginia Center for Diabetes Technology
Start Date
2025-07-23
Trial ID
NCT06948760
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability, pharmaco...
Status
Recruiting
Location
Yonsei University Health System, Severance Hospital
Start Date
2025-04-22
Trial ID
NCT07172802
Treatments Being Tested
This study was a pilot, safety, and pharmacokinetic study of MB-102 versus ...
Status
Completed
Location
Riverside Clinical Research
Start Date
2016-05-11
Trial ID
NCT02772276